XML 72 R66.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Condensed Consolidating Financial Statements of Aramark and Subsidiaries - Statements of Income And Comprehensive Income (Details) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 27, 2019
Dec. 28, 2018
Condensed Financial Statements, Captions [Line Items]    
Revenue $ 4,253,597 $ 4,265,349
Cost of services provided 3,768,113 3,794,445
Costs and Expenses:    
Depreciation and amortization 147,936 150,721
Selling and general corporate expenses 83,255 104,130
Gain on sale of Healthcare Technologies 0 (157,309)
Interest and other financing costs, net 79,585 82,978
Expense allocations 0 0
Total Costs and Expenses 4,078,889 3,974,965
Income (Loss) before Income Tax 174,708 290,384
Provision (Benefit) for Income Taxes 28,825 39,708
Equity in Net Income of Subsidiaries 0 0
Net income 145,883 250,676
Less: Net income (loss) attributable to noncontrolling interest 122 (6)
Net income attributable to Aramark stockholders 145,761 250,682
Other comprehensive loss, net of tax 21,200 (41,773)
Comprehensive income attributable to Aramark stockholders 166,961 208,909
Eliminations    
Condensed Financial Statements, Captions [Line Items]    
Revenue 0 0
Cost of services provided 0 0
Costs and Expenses:    
Depreciation and amortization 0 0
Selling and general corporate expenses 0 0
Gain on sale of Healthcare Technologies   0
Interest and other financing costs, net 0 0
Expense allocations 0 0
Total Costs and Expenses 0 0
Income (Loss) before Income Tax 0 0
Provision (Benefit) for Income Taxes 0 0
Equity in Net Income of Subsidiaries (145,761) (250,682)
Net income (145,761) (250,682)
Less: Net income (loss) attributable to noncontrolling interest 0 0
Net income attributable to Aramark stockholders (145,761) (250,682)
Other comprehensive loss, net of tax (46,048) 72,302
Comprehensive income attributable to Aramark stockholders (191,809) (178,380)
Aramark (Parent) | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Revenue 0 0
Cost of services provided 0 0
Costs and Expenses:    
Depreciation and amortization 0 0
Selling and general corporate expenses 0 0
Gain on sale of Healthcare Technologies   0
Interest and other financing costs, net 0 0
Expense allocations 0 0
Total Costs and Expenses 0 0
Income (Loss) before Income Tax 0 0
Provision (Benefit) for Income Taxes 0 0
Equity in Net Income of Subsidiaries 145,761 250,682
Net income 145,761 250,682
Less: Net income (loss) attributable to noncontrolling interest 0 0
Net income attributable to Aramark stockholders 145,761 250,682
Other comprehensive loss, net of tax 21,200 (41,773)
Comprehensive income attributable to Aramark stockholders 166,961 208,909
Issuers | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Revenue 268,435 268,522
Cost of services provided 246,308 246,609
Costs and Expenses:    
Depreciation and amortization 11,944 4,472
Selling and general corporate expenses 30,179 55,742
Gain on sale of Healthcare Technologies   0
Interest and other financing costs, net 74,769 78,560
Expense allocations (69,599) (230,589)
Total Costs and Expenses 293,601 154,794
Income (Loss) before Income Tax (25,166) 113,728
Provision (Benefit) for Income Taxes (7,352) 8,741
Equity in Net Income of Subsidiaries 0 0
Net income (17,814) 104,987
Less: Net income (loss) attributable to noncontrolling interest 0 0
Net income attributable to Aramark stockholders (17,814) 104,987
Other comprehensive loss, net of tax 8,018 (27,351)
Comprehensive income attributable to Aramark stockholders (9,796) 77,636
Guarantors | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Revenue 2,840,056 2,848,927
Cost of services provided 2,473,177 2,464,602
Costs and Expenses:    
Depreciation and amortization 109,237 120,982
Selling and general corporate expenses 46,240 41,552
Gain on sale of Healthcare Technologies   (157,309)
Interest and other financing costs, net 645 971
Expense allocations 65,378 225,801
Total Costs and Expenses 2,694,677 2,696,599
Income (Loss) before Income Tax 145,379 152,328
Provision (Benefit) for Income Taxes 22,209 25,000
Equity in Net Income of Subsidiaries 0 0
Net income 123,170 127,328
Less: Net income (loss) attributable to noncontrolling interest 122 (6)
Net income attributable to Aramark stockholders 123,048 127,334
Other comprehensive loss, net of tax 1,486 0
Comprehensive income attributable to Aramark stockholders 124,534 127,334
Non Guarantors | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Revenue 1,145,106 1,147,900
Cost of services provided 1,048,628 1,083,234
Costs and Expenses:    
Depreciation and amortization 26,755 25,267
Selling and general corporate expenses 6,836 6,836
Gain on sale of Healthcare Technologies   0
Interest and other financing costs, net 4,171 3,447
Expense allocations 4,221 4,788
Total Costs and Expenses 1,090,611 1,123,572
Income (Loss) before Income Tax 54,495 24,328
Provision (Benefit) for Income Taxes 13,968 5,967
Equity in Net Income of Subsidiaries 0 0
Net income 40,527 18,361
Less: Net income (loss) attributable to noncontrolling interest 0 0
Net income attributable to Aramark stockholders 40,527 18,361
Other comprehensive loss, net of tax 36,544 (44,951)
Comprehensive income attributable to Aramark stockholders $ 77,071 $ (26,590)